The "MS in the 21st Century" initiative was established with the purpose of (1) defining how multiple sclerosis (MS) treatment and standards of care should look in the 21st century; (2) developing a minimum standard of care across the world; and (3) motivating the broad MS community to align standards of care and challenge the current treatment paradigm. The aim was to develop a consensus statement to reach and influence the broader MS community. An expert steering group from Europe and Canada-consisting of neurologists, patient advocates, a pharmacoepidemiologist/pharmacoeconomist, and representatives from national MS centers-participated in a series of workshop-driven meetings between February 2011 and 2012. After three phases of discussi...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Sixteen years ago, there were no licensed treatments for multiple sclerosis (MS). Today, there are s...
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective...
The "MS in the 21st Century" initiative was established with the purpose of (1) defining how multipl...
The Author(s) 2012. This article is published with open access at Springerlink.com Abstract The ‘‘MS...
BACKGROUND: Patient engagement is vital in multiple sclerosis (MS) in order to optimise outcomes fo...
Objective. To provide recommendations on the use of disease-modifying agents in the management of mu...
Introduction. There are not many conditions in which the last few decades have brought such a major ...
Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease...
While advances in medicine, technology and healthcare services offer promises of longevity and impro...
While advances in medicine, technology and healthcare services offer promises of longevity and impro...
Background: Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur ...
Objective To compare patient and clinician experiences of MS-managment, to identify whether their vi...
• Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactori...
The management of multiple sclerosis (MS) is changing at a rapid rate, with the emergence of a host ...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Sixteen years ago, there were no licensed treatments for multiple sclerosis (MS). Today, there are s...
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective...
The "MS in the 21st Century" initiative was established with the purpose of (1) defining how multipl...
The Author(s) 2012. This article is published with open access at Springerlink.com Abstract The ‘‘MS...
BACKGROUND: Patient engagement is vital in multiple sclerosis (MS) in order to optimise outcomes fo...
Objective. To provide recommendations on the use of disease-modifying agents in the management of mu...
Introduction. There are not many conditions in which the last few decades have brought such a major ...
Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease...
While advances in medicine, technology and healthcare services offer promises of longevity and impro...
While advances in medicine, technology and healthcare services offer promises of longevity and impro...
Background: Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur ...
Objective To compare patient and clinician experiences of MS-managment, to identify whether their vi...
• Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactori...
The management of multiple sclerosis (MS) is changing at a rapid rate, with the emergence of a host ...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Sixteen years ago, there were no licensed treatments for multiple sclerosis (MS). Today, there are s...
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective...